Pixicam 20 mg. Dispersible tablets
PDF Leaflet Revision Date: 08 May 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Used for musculoskeletal and joint disorders.
Dosage (summary)
Starting dose 20 mg daily; 40 mg for acute conditions.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Contraindicated in late pregnancy; not recommended during lactation.
Key Drug Interactions
- Increased risk of GI bleeding with SSRIs
- Reduced plasma concentration with aspirin
Contraindications
- Hypersensitivity to piroxicam
- Active peptic ulcer
- Severe renal or hepatic insufficiency
Common side effects
- Gastrointestinal discomfort
- Dizziness
- Skin rash
Counselling Points
- Take with food to minimize GI upset
- Report any skin reactions immediately
- Avoid alcohol during treatment
Serious warnings
- Risk of serious GI events
- Potential for SJS and TEN
- Cardiovascular risks
Important Disclaimer
The Pixicam 20 mg. Dispersible tablets professional information leaflet below is the property of Kiara Health and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
